S. Verstappen

Determinants of direct costs in Dutch rheumatoid arthritis patients

Verstappen, S, Verkleij, H, Bijlsma, J, Buskens, E, Kruize, A, Heurkens, A, ...

Objectives: To estimate annual direct costs in four distinct disease duration groups (0 to ⩽2, 2 to ⩽6, 6 to ⩽10, and >10 years) of patients with rheumatoid arthritis (RA), to determine...

A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up

Verstappen, S, Van Albada-Kuiper..., G A, Bijlsma, J, Blaauw, A, Schenk, Y, Haanen, H, ...

Objective: To describe the frequency and duration of remission in the Utrecht rheumatoid arthritis cohort of patients followed since diagnosis, and the clinical and treatment characteristics of...